SG11201804540WA - Resorbable crosslinked form stable membrane - Google Patents

Resorbable crosslinked form stable membrane

Info

Publication number
SG11201804540WA
SG11201804540WA SG11201804540WA SG11201804540WA SG11201804540WA SG 11201804540W A SG11201804540W A SG 11201804540WA SG 11201804540W A SG11201804540W A SG 11201804540WA SG 11201804540W A SG11201804540W A SG 11201804540WA SG 11201804540W A SG11201804540W A SG 11201804540WA
Authority
SG
Singapore
Prior art keywords
collagen
international
collagen material
composite layer
inorganic ceramic
Prior art date
Application number
SG11201804540WA
Inventor
Niklaus Stiefel
Sergej Stenzel
Raphael Kaufmann
Original Assignee
Geistlich Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geistlich Pharma Ag filed Critical Geistlich Pharma Ag
Publication of SG11201804540WA publication Critical patent/SG11201804540WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A61C8/0003Not used, see subgroups
    • A61C8/0004Consolidating natural teeth
    • A61C8/0006Periodontal tissue or bone regeneration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2/2846Support means for bone substitute or for bone graft implants, e.g. membranes or plates for covering bone defects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/12Materials or treatment for tissue regeneration for dental implants or prostheses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Dentistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Polymers & Plastics (AREA)

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property -' International Bureau res.. 00) (43) International Publication Date ..... ..sr ,„„*.) 8 June 2017 (08.06.2017) W I P0 1 PCT Organization 111111111111311111111111111111111111111111111111111111111111111111111111111111111111111111 (10) WO International 2017/093502 Publication Al Number (51) International Patent Classification: DO, DZ, EC, EE, EG, A61L 27/38 (2006.01) A61L 27/58 (2006.01) HN, HR, HU, ID, IL, A61L 27/46 (2006.01) KW, KZ, LA, LC, LK, MG, MK, MN, MW, (21) International Application Number: OM PA, PE, PG, PH, PCT/EP2016/079622 SC, SD, SE, SG, SK, (22) International Filing Date: TN, TR, TT, TZ, UA, 2 December 2016 (02.12.2016) ZW. (25) Filing Language: English (8 4 ) Designated States (unless kind of regional protection (26) Publication Language: English GM, KE, LR, LS, MW, (30) Priority Data: TZ, UG, ZM, ZW), Eurasian (AM, 15198070.3 4 December 2015 (04.12.2015) EP TJ, TM), European (AL, DK, EE, ES, FI, FR, (71) Applicant: GEISTLICH PHARMA AG [CH/CH]; LV, MC, MK, MT, NL, Bahnhofstrasse 40, 6110 Wolhusen (CH). SM, TR), OAPI (BF, ES, FI, GB, GD, GE, GH, GM, GT, IN, IR, IS, LR, LS, MX, MY, PL, PT, SL, SM, UG, MZ, AT, GB, GR, NO, BJ, CF, otherwise available): JP, KE, KG, KN, KP, KR, LU, LY, MA, MD, ME, MZ, NA, NG, NI, NO, NZ, QA, RO, RS, RU, RW SA, ST, SV, SY, TH, TJ, TM, US, UZ, VC, VN, ZA, ZM, indicated, for every ARIPO (BW, GH, NA, RW, SD, SL, ST, SZ, AZ, BY, KG, KZ, RU, BE, BG, CH, CY, CZ, DE, HR, HU, IE, IS, IT, LT, LU, PL, PT, RO, RS, SE, SI, SK, CG, CI, CM, GA, GN, GQ, (72) Inventors: STIEFEL, Niklaus; Waldstatterstrasse 31, GW, KM, ML, MR, NE, 6003 Luzern (CH). STENZEL, Sergej; Dobeligut 8, 4665 Declarations under Rule 4.17: Oftringen (CH). KAUFMANN, Raphael; Neuheim 8, — as to the identity of the 6275 Ballwil (CH). — as to applicant's entitlement TG). SN, TD, inventor to (Rule 4.17(0) apply for and be granted a (74) Agent: SAVATIER, Yves; Bahnhofstrasse 40, 6110 patent (Rule 4.170) Wolhusen (CH). Published: (81) Designated States (unless otherwise indicated, for every kind AE, AG, AL, AM, — with international search report (Art 21(3)) of national protection available): AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, (54) Title: RESORBABLE CROSSLINKED FORM STABLE MEMBRANE 1 Fig r Il .4t (57) : The invention relates to: -A resorbable crosslinked form stable membrane which comprises a composite layer of col - ei c ::: : , lagen material and inorganic ceramic particles containing 1.5 to 3.5 weight parts of inorganic ceramic for 1 weight part of collagen If) material, sandwiched between two layers of elastic pretensed collagen material, the collagen material comprising 50-100 % (w/w) M collagen and 0-50 % (w/w) elastin, -the above crosslinked resorbable crosslinked form stable membrane for use as an implant to sup - CT\ o port bone formation, bone regeneration, bone repair and/or bone replacement at a non-containing dental bony defect site in a human ---... or animal, -a process for preparing the above crosslinked resorbable crosslinked foiin stable membrane comprising the steps of: (a) Preparing a composite layer of inorganic ceramic particles and collagen material, optionally crosslinking that composite layer, (b) ..::::; Assembling and glueing the composite layer of collagen material and inorganic ceramic particles between two layers of collagen ma - ei terial submitted to tensioning leading to a stretching of the collagen material in the linear region of the stress-strain curve, thereby ega ) giving a composite layer of collagen material and inorganic ceramic particles sandwiched between two layers of elastic pretensed :',.1: collagen material, and (c) Crosslinking that composite layer of collagen material and inorganic ceramic particles sandwiched between two layers of elastic pretensed collagen material, followed by a hydrophilic making treatment.
SG11201804540WA 2015-12-04 2016-12-02 Resorbable crosslinked form stable membrane SG11201804540WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15198070.3A EP3175869A1 (en) 2015-12-04 2015-12-04 Resorbable crosslinked formstable membrane
PCT/EP2016/079622 WO2017093502A1 (en) 2015-12-04 2016-12-02 Resorbable crosslinked form stable membrane

Publications (1)

Publication Number Publication Date
SG11201804540WA true SG11201804540WA (en) 2018-06-28

Family

ID=54782622

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201804540WA SG11201804540WA (en) 2015-12-04 2016-12-02 Resorbable crosslinked form stable membrane

Country Status (20)

Country Link
US (1) US10300171B2 (en)
EP (2) EP3175869A1 (en)
JP (2) JP6571872B2 (en)
KR (1) KR101918908B1 (en)
CN (2) CN110404116A (en)
AU (1) AU2016361929B2 (en)
BR (1) BR112018009975B1 (en)
CA (1) CA3006693C (en)
DK (1) DK3233146T3 (en)
ES (1) ES2675230T3 (en)
HK (1) HK1245681B (en)
HU (1) HUE037840T2 (en)
IL (1) IL259776B (en)
MX (1) MX2018006786A (en)
PL (1) PL3233146T3 (en)
PT (1) PT3233146T (en)
RU (1) RU2733387C9 (en)
SG (1) SG11201804540WA (en)
TR (1) TR201809139T4 (en)
WO (1) WO2017093502A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3175869A1 (en) 2015-12-04 2017-06-07 Geistlich Pharma AG Resorbable crosslinked formstable membrane
EP3409303A1 (en) 2017-06-02 2018-12-05 Geistlich Pharma AG Use of a resorbable crosslinked form stable composition for preparing a membrane
AU2018383017B2 (en) * 2017-12-14 2024-04-11 Geistlich Pharma Ag Dried implant composition and injectable aqueous implant formulation
KR101938263B1 (en) * 2018-07-31 2019-01-14 강호창 Manufacturing method for dental dual structure membrane
EP3941542B1 (en) * 2019-06-14 2022-12-28 Geistlich Pharma AG Injectable aqueous implant formulation containing ascorbic acid
CN111758763B (en) * 2020-07-07 2021-12-14 山东大树达孚特膳食品有限公司 Fat removing equipment for intestines and stomach
CN114425104B (en) * 2021-12-21 2023-03-03 中国人民解放军空军军医大学 Medicine-carrying bone guiding/inducing composite structure and preparation method and application thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813033D0 (en) 1988-06-02 1988-07-06 Geistlich Soehne Ag Chemical compound
JPH0788174A (en) * 1993-09-28 1995-04-04 Yamanouchi Pharmaceut Co Ltd Implant for osteogenesis
GB9400163D0 (en) 1994-01-06 1994-03-02 Geistlich Soehne Ag Membrane
JP3592920B2 (en) * 1998-01-19 2004-11-24 独立行政法人物質・材料研究機構 Method for producing organic-inorganic oriented composite material
JP4790917B2 (en) * 2001-02-23 2011-10-12 独立行政法人科学技術振興機構 Artificial vertebral body
AU784394B2 (en) * 2001-04-27 2006-03-23 Geistlich Pharma Ag Method and membrane for mucosa regeneration
GB0121985D0 (en) * 2001-09-11 2001-10-31 Isis Innovation Tissue engineering scaffolds
RU2274461C2 (en) * 2004-02-26 2006-04-20 Сергей Дмитриевич Литвинов Material for replacing osseous tissue defect and method for its preparing
ITMI20050343A1 (en) * 2005-03-04 2006-09-05 Fin Ceramica Faenza S R L CARTRIDGE REPLACEMENT AND OSTEOCINDRAL INCLUDING A MULTILAYER STRUCTURE AND ITS USE
RU2551009C2 (en) * 2009-01-16 2015-05-20 Гайстлих Фарма Аг Method and membrane for skin regeneration
EP2467172A1 (en) 2009-08-10 2012-06-27 Osseous Technologies Of America Self-supporting collagen tunnel for guided tissue regeneration and method of using same
DE102010001271B8 (en) * 2010-01-27 2012-12-06 Urotiss Gmbh A suturable tissue graft construct for reconstructing a human or animal organ
GB201003656D0 (en) 2010-03-05 2010-04-21 Tigenix Ltd Fabrication process
EP2508212A1 (en) * 2011-04-05 2012-10-10 Universitätsklinikum Freiburg Biocompatible and biodegradable gradient layer system for regenerative medicine and for tissue support
RU2476236C1 (en) * 2012-02-16 2013-02-27 Общество С Ограниченной Ответственностью "Ниармедик Плюс" Composite for bone tissue defect repair, method for producing and using it
TWM435257U (en) * 2012-04-27 2012-08-11 Shih-Cheng Wen Composite regeneration membrane
CN102805881B (en) * 2012-06-18 2014-02-19 浙江星月生物科技股份有限公司 Collagen basal bone cartilage three-layer compound and preparation method thereof
US9943551B2 (en) * 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
US20140193477A1 (en) 2012-10-11 2014-07-10 Emory University Collagen based materials and uses related thereto
DE102012024206A1 (en) * 2012-12-05 2014-06-18 Celgen Ag Multi-layered membrane for bone defects
CN104922732B (en) * 2014-03-19 2019-11-15 天新福(北京)医疗器材股份有限公司 A kind of oral biological film preparation method
EP3175869A1 (en) * 2015-12-04 2017-06-07 Geistlich Pharma AG Resorbable crosslinked formstable membrane

Also Published As

Publication number Publication date
DK3233146T3 (en) 2018-07-16
WO2017093502A1 (en) 2017-06-08
EP3233146B1 (en) 2018-05-09
IL259776A (en) 2018-07-31
EP3233146A1 (en) 2017-10-25
RU2733387C9 (en) 2020-10-20
TR201809139T4 (en) 2018-07-23
BR112018009975A2 (en) 2018-11-13
HUE037840T2 (en) 2018-09-28
PL3233146T3 (en) 2018-08-31
CA3006693A1 (en) 2017-06-08
KR20180066902A (en) 2018-06-19
IL259776B (en) 2021-01-31
AU2016361929B2 (en) 2021-05-20
BR112018009975B1 (en) 2020-03-10
RU2733387C2 (en) 2020-10-01
EP3175869A1 (en) 2017-06-07
JP2019162503A (en) 2019-09-26
CA3006693C (en) 2020-09-22
ES2675230T3 (en) 2018-07-09
AU2016361929A1 (en) 2018-06-14
JP2018537193A (en) 2018-12-20
CN108289976B (en) 2019-10-25
RU2018119921A3 (en) 2020-01-20
HK1245681B (en) 2019-06-28
JP6571872B2 (en) 2019-09-04
MX2018006786A (en) 2018-08-01
CN110404116A (en) 2019-11-05
US10300171B2 (en) 2019-05-28
PT3233146T (en) 2018-07-11
KR101918908B1 (en) 2018-11-14
CN108289976A (en) 2018-07-17
US20180256785A1 (en) 2018-09-13
RU2018119921A (en) 2020-01-09

Similar Documents

Publication Publication Date Title
SG11201804540WA (en) Resorbable crosslinked form stable membrane
SG11201910191RA (en) A peptide capable of forming a gel for use in tissue engineering and bioprinting
SG11201807965YA (en) Combinations of lsd1 inhibitors for use in the treatment of solid tumors
SG11201906297QA (en) Nucleic acids encoding crispr-associated proteins and uses thereof
SG11201907804QA (en) Pharmaceutical composition comprising selexipag
SG11201804152RA (en) Heterocyclic compounds as immunomodulators
SG11201901390TA (en) Tetracycline compounds and methods of treatment
SG11201810628XA (en) Nasal pharmaceutical compositions with a porous excipient
SG11201907402SA (en) Population-based immunogenic peptide identification platform
SG11201900618WA (en) Permanently polarized hydroxyapatite, a process for its manufacture and uses thereof
SG11201908971RA (en) Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene
SG11201808566WA (en) Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide
SG11201901534VA (en) Combination therapy with controlled-release cnp agonists
SG11201807972YA (en) Combinations of lsd1 inhibitors for the treatment of hematological malignancies
SG11201907604UA (en) Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
SG11201906959RA (en) Aryl hydrocarbon receptor (ahr) modulator compounds
SG11201807185UA (en) Modified hyaluronic acid, method for making same and uses thereof
SG11201810352XA (en) New antibacterial compounds
SG11201807963WA (en) Compositions useful in the prevention and/or treatment of disorders of the oral cavity, upper airways and esophagus
SG11201805195YA (en) Composition comprising botulinum toxin
SG11201900471VA (en) Combination therapy for copd
SG11201901137UA (en) Silk-derived protein for treating inflammation
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201901249YA (en) Aza-indazole compounds for use in tendon and/or ligament injuries
SG11201909107YA (en) Stenosis treatment